[1] |
Song Chenlu, Qi Xiaojing, Chen Yipeng, Xing Guangqun.
Association of poor living habits and smoking with primary membranous nephropathy
[J]. Clinical Focus, 2025, 40(6): 513-518.
|
[2] |
Zhao Xueting, Bai Jiawen, Sun Jun.
Analysis of risk factors for liver fibrosis in metabolic dysfunction-associated fatty liver disease and construction of a nomogram
[J]. Clinical Focus, 2025, 40(5): 417-422.
|
[3] |
Tong Mingxia, Chen Ke, Xiang Xiaocong, Zhou Lifeng.
Analysis of lean metabolic-associated fatty liver disease among young and middle-aged people and its risk factors
[J]. Clinical Focus, 2025, 40(2): 128-132.
|
[4] |
Shi Shuangwei, Rao Xiaojuan, Xie Liran, Fang Yifan, Wang Shanshan.
Correlation between thyroid hormone sensitivity and non-alcoholic fatty liver in type 2 diabetes mellitus patients with normal thyroid function
[J]. Clinical Focus, 2025, 40(2): 133-137.
|
[5] |
Gou Caixia, Zhang Jie, Baoyixiamu·Ababaikeli , Wang Yiming, Yao Lei, Zheng Rongjiong, Pan Jinliang, Lu Xiaobo.
Analysis of influencing factors of sleep quality and metabolically associated fatty liver disease in the physical examination population
[J]. Clinical Focus, 2025, 40(1): 33-38.
|
[6] |
Xiong Lu, Guo Lian.
Correlation of 25(OH)D and SUA/SCr with type 2 diabetes mellitus combined with non-alcoholic fatty liver disease
[J]. Clinical Focus, 2024, 39(8): 706-711.
|
[7] |
Wu Qiupin, Yan Shiwei, He Xiaoyin, Li Yun, LU Liju, Wu Yi.
Analysis of hepatitis associated aplastic anemia in children
[J]. Clinical Focus, 2024, 39(7): 640-643.
|
[8] |
Liang Yi.
Meta-analysis of effects of curcumin on inflammation and oxidative stress of patients with type 2 diabetes mellitus
[J]. Clinical Focus, 2024, 39(11): 974-979.
|
[9] |
Cao Yumeng, Zhang Haiyan, Liu Lixin.
Correlation between pathological changes and serum ferritin and iron levels in nonalcoholic fatty liver disease: A meta-analysis
[J]. Clinical Focus, 2023, 38(3): 197-207.
|
[10] |
Wang Wenqi, Zhang Tao.
Effect of semaglutide on total myocardial ischemic burden and serum inflammatory factors in patients with type 2 diabetes mellitus complicated with coronary heart disease
[J]. Clinical Focus, 2022, 37(11): 996-1000.
|
[11] |
Wen Jie.
Correlation analysis between atherogenic index of plasma and nonalcoholic fatty liver disease
[J]. Clinical Focus, 2022, 37(1): 35-38.
|
[12] |
Luo Fanglin, Guan Suying, Wu Guoxiang.
Clinical effect of sacubitril-valsartan combined with activin on acute left heart failure
[J]. Clinical Focus, 2021, 36(9): 782-785.
|
[13] |
Li Dan, Hua Guohui.
Application value of cerebrospinal fluid and serum PCT and CRP in diagnosis of central nervous system infection
[J]. Clinical Focus, 2021, 36(8): 704-707.
|
[14] |
Li Guohuan, Xie Xu, Huang Zhixia, Zhang Mingye, Tang Yunyun.
Quantitative evaluation of transient elastography and acoustic radiation force pulse imaging for non-alcoholic fatty liver disease
[J]. Clinical Focus, 2021, 36(6): 535-539.
|
[15] |
Wang Shimeng, Ma Yingji, Wu Ying, Liu Xiaodan, Wang Wei.
Effects of HBV infection on liver metastasis of tumor: A meta-analysis
[J]. Clinical Focus, 2021, 36(5): 389-394.
|